{"url":"https://lda.senate.gov/api/v1/filings/8d51547c-60c2-4e9b-aaa5-bca2afcf7f70/","filing_uuid":"8d51547c-60c2-4e9b-aaa5-bca2afcf7f70","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8d51547c-60c2-4e9b-aaa5-bca2afcf7f70/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tracy Spicer","dt_posted":"2021-04-20T12:45:48.267000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th St. NW","registrant_address_2":"Suite 720","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":72111,"url":"https://lda.senate.gov/api/v1/registrants/72111/","house_registrant_id":35940,"name":"AVENUE SOLUTIONS","description":"Government representation","address_1":"401 9th St. NW","address_2":"Suite 720","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY TEJRAL","contact_telephone":"+1 202-347-9848","dt_updated":"2026-01-30T17:55:20.768017-05:00"},"client":{"id":165824,"url":"https://lda.senate.gov/api/v1/clients/165824/","client_id":1004494,"name":"SAGE THERAPEUTICS, INC.","general_description":"Pharmaceutical manufacturing","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-06-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Education and awareness of mental health issues, particularly postpartum depression;\n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);\n\nH.R. 1319, American Rescue Plan Act of 2021 (PL 117-2)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48260,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"MACDONALD","last_name":"BARNETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23462,"prefix":null,"prefix_display":null,"first_name":"TRACY","nickname":null,"middle_name":null,"last_name":"SPICER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}